{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-21-017175","form_type":"8-K","ticker":"AUPH","cik":"0001600620","company_name":"Aurinia Pharmaceuticals Inc.","filed_at":"2021-08-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.754108+00:00","generated_at":"2026-06-29T09:34:17.301570+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Aurinia licenses novel peptide AUR300 from Riptide for autoimmune/fibrotic diseases; $6M upfront","bullets":["Global licensing/research pact with Riptide for peptide AUR300 targeting M2 macrophages via CD206 receptor.","Aurinia pays $6M upfront; potential milestones and royalties on future sales of AUR300.","AUR300 reduces M2 dysregulation and inflammatory cytokines, aiming to treat autoimmune and fibrotic diseases.","Joint development committee formed; Riptide handles tech transfer and indication research activities.","Deal expands Aurinia's pipeline beyond LUPKYNIS into fibrosis and other autoimmune conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-21-017175","json":"https://secwatch.observer/filing/0001628280-21-017175.json","markdown":"https://secwatch.observer/filing/0001628280-21-017175.md","text":"https://secwatch.observer/filing/0001628280-21-017175.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1600620/000162828021017175/0001628280-21-017175-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1600620/000162828021017175/auph-20210817.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T09:34:17.301570+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}